News & Events about 2seventy Bio Inc.
Milestone payment is related to the establishment of 2seventy bios strategic partnership with JW TherapeuticsPayment provides further validation of Medigenes end-to-end platform MARTINSRIED, Germany and MUNICH, Germany, Jan. 18, 2023 (GLOBE NEWSWIRE) -- Martinsried -- Medigene AG (Medigene, FSE: ...
2seventy bio (NASDAQ:TSVT Get Rating) had its price target reduced by SVB Leerink from $41.00 to $34.00 in a research report released on Tuesday, Benzinga reports. They currently have an outperform rating on the stock. SVB Leerink also issued estimates for 2seventy bios Q4 2022 ...
2seventy bio, Inc. (Nasdaq: TSVT) today announced an amendment to its collaboration with Regeneron that will facilitate an expanded and accelerated development plan for novel cell therapy-based combinations for solid tumors. The collaboration will leverage 2seventy bios unique cell therapy...
2seventy bio, Inc. (NASDAQ:TSVT Get Rating) insider Philip D. Gregory sold 2,407 shares of the companys stock in a transaction on Friday, August 5th. The stock was sold at an average price of $16.23, for a total value of $39,065.61. Following the sale, the insider now owns 104,388 shares of the ...